Beta-adrenergic receptors are expressed across diverse cancers

Based largely on retrospective analyses and a handful of prospective case reports, pharmacological inhibition of the beta adrenergic receptors using beta blockers has shown clinical anti-cancer efficacy in reproductive cancers, as well as angiosarcoma and multiple myeloma. Because of the potential p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rains, Steven L., Amaya, Clarissa N., Bryan, Brad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616202/
https://www.ncbi.nlm.nih.gov/pubmed/28966942
http://dx.doi.org/10.18632/oncoscience.357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616202/
https://www.ncbi.nlm.nih.gov/pubmed/28966942
http://dx.doi.org/10.18632/oncoscience.357

Ejemplares similares